glp-1 vs bariatric surgery Metabolic vs. Receptor Agonists for Obesity Management Bariatric Surgery vs GLP-1 Medication:

doi: 10.1152/ajprenal.00394.2015 101 ThomsonSCKashkouliASinghP

The radiation protection regulations from the International Commission for Radiological Protection (ICRP) set the limit for occupational exposure to 20 mSv per year of effective dose, averaged over a defined period of 5 years (100 mSv in 5 year), with no yearly dose exceeding 50 mSv (200)

Somatostatin is the brake on GH release

When combining GLP-1 receptor agonists with insulin or sulfonylureas, the chance of experiencing hypoglycemia (low blood sugar) goes up

Dosing generally starts low and increases over the first several months based on tolerance and results